Avient Corporation
NYSE:AVNTChemicals - Specialty
+$0.04 today
- Market cap
- $4.07B
- Beta
- 1.30
- P/E (TTM)
- 21.4
- EPS (TTM)
- $1.72
- Dividend yield
- 2.97%
Volume 0.55M
Average 0.74M
AVNT Cost of Revenue
Direct costs of producing the goods and services sold, such as materials, manufacturing, and service delivery.
Avient CorporationNYSE: AVNT
Cost of Revenue · Q3 FY2026 · quarter ended Sep 2026
Cost of revenue growth accelerates
Q3 FY2026 cost of revenue of $619.4M rose 10.3% year over year, ahead of the +5.3% change in trailing-twelve-month cost of revenue. Sequentially, it rose 1.6% from the prior quarter. Over 3 fiscal years it compounded at -4.3% a year.
Context
- Cost of revenue amounted to 67.5% of revenue in FY2025, up 0.2 pp from a year earlier.
- Cost of revenue increased in 1 of the last 3 fiscal years.
What to watch
Whether quarterly growth of +10.3% holds above the trailing-twelve-month pace of +5.3%.
Sources:Income StatementText generated from reported figures; not investment advice.
Cost of Revenue history
USD · from the income statement
- Latest · FY2025
- 2.2B USD
- Year-over-year change
- +0.8%
- 4-year CAGR
- -1.8%
| Period | Period end | Cost of Revenue | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 2.2B | +0.8% |
| FY2024 | 2024-12-31 | 2.18B | -2.5% |
| FY2023 | 2023-12-31 | 2.24B | -10.9% |
| FY2022 | 2022-12-31 | 2.51B | +6.0% |
| FY2021 | 2021-12-31 | 2.37B | — |
Cost of Revenue vs competitors
How AVNT compares with its peers on the latest reported figures
- AVNT's LTM Sep 2026 cost of revenue of $2.32B is the 5th highest of the 11 companies compared; the peer median is $1.78B.
- Its year-over-year change of +5.3% is the 6th highest of 11, against a peer median of +3.7%.
- Cost of revenue amounts to 67.9% of revenue for AVNT, versus a peer median of 71.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $6.17B | +1.4% | -4.4% | 92.0% | |
| LTM Jun 2026 | $3.05B | +13.2% | -8.0% | 71.4% | |
| LTM Jun 2026 | $2.8B | -1.9% | -6.9% | 77.1% | |
| LTM Aug 2026 | $2.39B | -1.6% | -5.2% | 67.2% | |
| LTM Sep 2026 | $2.32B | +5.3% | -4.3% | 67.9% | |
| LTM Sep 2026 | $2.26B | -1.2% | -6.0% | 75.3% | |
| LTM Jun 2026 | $1.3B | -5.9% | -6.5% | 70.6% | |
| LTM Jun 2026 | $1.11B | +5.9% | +4.2% | 65.4% | |
| LTM Sep 2026 | $883.82M | +9.4% | +3.8% | 77.6% | |
| LTM Jun 2026 | $389.54M | +51.8% | +6.2% | 51.5% | |
| LTM Aug 2026 | $307.5M | +10.4% | +5.3% | 44.7% | |
| Peer median (excluding AVNT) | $1.78B | +3.7% | -4.8% | 71.0% | |
Competitors are the stored peer set for AVNT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 3.32B | 3.4B | 3.14B | 3.24B | 3.26B |
| Cost of Revenue | 2.37B | 2.51B | 2.24B | 2.18B | 2.2B |
| Gross Profit | 943.8M | 882.7M | 902.7M | 1.06B | 1.06B |
| Gross Margin | 28.5% | 26.0% | 28.7% | 32.6% | 32.5% |
| Research & Development | 0 | 84.9M | 90.3M | 98.7M | 0 |
| Selling, General & Admin | 664.1M | 639.4M | 590.9M | 727.4M | 695.4M |
| Operating Expenses | 664.1M | 639.4M | 681.2M | 727.4M | 854.7M |
| Depreciation & Amortization | 145.9M | 163.1M | 188.8M | 179.7M | 185.9M |
| EBITDA | 424.6M | 346.7M | 391.4M | 510.1M | 548.7M |
| EBITDA Margin | 12.8% | 10.2% | 12.5% | 15.7% | 16.8% |
| Operating Income | 279.7M | 243.3M | 221.5M | 329.3M | 203.5M |
| Operating Margin | 8.4% | 7.2% | 7.0% | 10.2% | 6.2% |
| Interest Income | 17.5M | 34M | 0 | 0 | 0 |
| Interest Expense | 105.1M | 182.3M | 115.3M | 105.6M | 98.6M |
| Other Income / Expenses | (76.2M) | (179.5M) | (134.2M) | (104.5M) | (91.8M) |
| Income Before Tax | 203.5M | 63.8M | 87.3M | 224.8M | 111.7M |
| Pre-Tax Margin | 6.1% | 1.9% | 2.8% | 6.9% | 3.4% |
| Income Tax Expense | 51.9M | (19.3M) | 11M | 54.1M | 28.1M |
| Net Income | 230.8M | 153M | 75.7M | 169.5M | 81.9M |
| Net Margin | 7.0% | 4.5% | 2.4% | 5.2% | 2.5% |
| EPS (Basic) | 2.53 | 7.71 | 0.83 | 1.86 | 0.90 |
| EPS (Diluted) | 2.51 | 1.66 | 0.82 | 1.84 | 0.89 |
| Weighted Avg Shares | 91.4M | 91.2M | 91.1M | 91.3M | 91.5M |
| Weighted Avg Shares (Diluted) | 92.1M | 92.2M | 91.8M | 92M | 91.8M |
Avient Corporation
NYSE:AVNT
Intrinsic Alpha fair value
Locked
Current Price
$44.34
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.